Mergers and Acquisitions Coverage - MedCity News https://medcitynews.com/tag/mergers-and-acquisitions/ Healthcare technology news, life science current events Thu, 06 Jun 2024 06:45:16 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.3 228111745 At BIO, Novo Nordisk’s Top Dealmaker Talks M&A Strategy and What’s Next After GLP-1s https://medcitynews.com/2024/06/at-bio-novo-nordisks-top-dealmaker-talks-ma-strategy-and-whats-next-after-glp-1s/ https://medcitynews.com/2024/06/at-bio-novo-nordisks-top-dealmaker-talks-ma-strategy-and-whats-next-after-glp-1s/#respond Wed, 05 Jun 2024 08:33:40 +0000 https://medcitynews.com/?p=126993

Novo Nordisk’s focus on diabetes and obesity shape its business development work, but the company is also exploring other areas. Top Novo Nordisk M&A executive John McDonald discussed his company’s strategy during a session at the BIO conference in San Diego.

The post At BIO, Novo Nordisk’s Top Dealmaker Talks M&A Strategy and What’s Next After GLP-1s appeared first on MedCity News.

]]>
https://medcitynews.com/2024/06/at-bio-novo-nordisks-top-dealmaker-talks-ma-strategy-and-whats-next-after-glp-1s/feed/ 0 126993
Cigna MA Sale to HCSC Could Still Clear Way for Humana Acquisition, Expert Says https://medcitynews.com/2024/02/cigna-medicare-advantage-sale-hcsc-humana/ Thu, 01 Feb 2024 22:39:00 +0000 https://medcitynews.com/?p=663138

Despite Cigna and Humana ditching their pursuits to combine in December, one industry expert believes there’s still a chance after Cigna announced its plan to sell its Medicare Advantage business to Health Care Service Corp.

The post Cigna MA Sale to HCSC Could Still Clear Way for Humana Acquisition, Expert Says appeared first on MedCity News.

]]>
86896
Deloitte: 7 Trends Shaping Healthcare and Life Sciences in 2024 https://medcitynews.com/2024/01/deloitte-trends-ai-healthcare/ Fri, 19 Jan 2024 20:47:43 +0000 https://medcitynews.com/?p=661671

AI, health equity and merger and acquisition activity are among the trends to watch in 2024, according to a recent report from Deloitte.

The post Deloitte: 7 Trends Shaping Healthcare and Life Sciences in 2024 appeared first on MedCity News.

]]>
86824
How Financial Pressures Are Shaping Hospital M&A Activity https://medcitynews.com/2024/01/hospital-finance-merger-acquisition/ Fri, 19 Jan 2024 20:44:21 +0000 https://medcitynews.com/?p=661668

Hospitals weathered one of their most challenging years in 2022, with median operating margins staying in the red throughout most of the year. Those money problems proved to be a major factor shaping last year’s M&A transactions — financial pressures influenced 28% of hospital M&A deals last year, up from 15% in 2022, a new report showed.

The post How Financial Pressures Are Shaping Hospital M&A Activity appeared first on MedCity News.

]]>
86823
How Can Hospitals Make the Post-Merger Transition As Smooth As Possible? https://medcitynews.com/2024/01/hospitals-merger-healthcare/ Sun, 07 Jan 2024 15:19:02 +0000 https://medcitynews.com/?p=660441

Experts have predicted that 2024 will be an eventful year for hospital M&A activity. As the industry prepares for another big year, there are a few things that health system leaders involved in these deals should keep in mind to make the process as smooth as possible, according to DexCare CEO Derek Streat.

The post How Can Hospitals Make the Post-Merger Transition As Smooth As Possible? appeared first on MedCity News.

]]>
86751
‘We’re Getting Closer and Closer To Bright Going Dark’: Molina Lowers Purchase Price for Bright Health Group’s MA Business https://medcitynews.com/2023/12/were-getting-closer-and-closer-to-bright-going-dark-molina-lowers-purchase-price-for-bright-health-groups-ma-business/ Wed, 20 Dec 2023 00:31:03 +0000 https://medcitynews.com/?p=659481

Molina Healthcare’s purchase price of Bright Health Group’s Medicare Advantage business has dropped from $600 million to $500 million. This will make it increasingly difficult for Bright Health to pay off its debts, one expert said.

The post ‘We’re Getting Closer and Closer To Bright Going Dark’: Molina Lowers Purchase Price for Bright Health Group’s MA Business appeared first on MedCity News.

]]>
10308
Navigating a Successful M&A Integration Process https://medcitynews.com/2023/12/navigating-a-successful-ma-integration-process/ Tue, 12 Dec 2023 19:31:10 +0000 https://medcitynews.com/?p=656982

Integrations are incredibly destabilizing and stressful for impacted employees, as well as for those who “survive.” Organizations that are worth acquiring are successful and attractive because they are comprised of smart, talented people who have created that success.

The post Navigating a Successful M&A Integration Process appeared first on MedCity News.

]]>
10023
Expert: The Rumored Humana/Cigna Combination Makes Sense https://medcitynews.com/2023/11/cigna-humana-mergers-acquisitions/ Thu, 30 Nov 2023 22:11:42 +0000 https://medcitynews.com/?p=657174

With Cigna mostly focused on the commercial market and Humana mostly focused on the Medicare Advantage market, the rumored combination rumors check out, according to one industry expert.

The post Expert: The Rumored Humana/Cigna Combination Makes Sense appeared first on MedCity News.

]]>
39780
Kyowa Kirin Buys Into Gene Therapy With Orchard Therapeutics Acquisition https://medcitynews.com/2023/10/gene-therapy-kyowa-kirin-orchard-therapeutics-acquisition/ Thu, 05 Oct 2023 16:43:57 +0000 https://medcitynews.com/?p=650925

The Orchard Therapeutics acquisition comes as the biotech’s gene therapy for metachromatic leukodystrophy approaches a March 2024 FDA decision. The ex vivo gene therapy is already commercialized in Europe, marketed as Libmeldy.

The post Kyowa Kirin Buys Into Gene Therapy With Orchard Therapeutics Acquisition appeared first on MedCity News.

]]>
44607
After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout https://medcitynews.com/2023/09/after-nash-hopes-are-dashed-intercept-pharma-agrees-to-794m-buyout/ Tue, 26 Sep 2023 17:22:56 +0000 https://medcitynews.com/?p=649905

Intercept Pharmaceuticals’ acquisition by Alfasigma comes three months after the FDA again rejected the biotech’s drug as a treatment for the fatty liver disease NASH. But Intercept still has rare liver disease assets, and Italy-based Alfasigma says acquiring the company will help it expand in gastroenterology and hepatology.

The post After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout appeared first on MedCity News.

]]>
44490
How the FTC Is Tackling ‘Below the Radar’ Healthcare Deals https://medcitynews.com/2023/09/how-the-ftc-is-tackling-below-the-radar-healthcare-deals/ Tue, 19 Sep 2023 17:06:23 +0000 https://medcitynews.com/?p=649113

The Federal Trade Commission only gets notified when a merger/acquisition deal value is above $100-$110 million, so smaller deals nonetheless lead to a slow consolidation of the market. In conference remarks, FTC Chair Lina Khan outlined the ways in which the agency is trying to counter this phenomenon.

The post How the FTC Is Tackling ‘Below the Radar’ Healthcare Deals appeared first on MedCity News.

]]>
44409
Nestlé Sells Peanut Allergy Drug, Ending the Food Giant’s Foray Into Biotech https://medcitynews.com/2023/09/nestle-peanut-allergy-drug-palforzia-stallergenes-greer/ Tue, 05 Sep 2023 23:06:06 +0000 https://medcitynews.com/?p=647667

Peanut allergy therapy Palforzia, which Nestlé acquired in a multi-billion dollar deal, has been sold to allergy product company Stallergenes Greer. Palforzia was the first FDA-approved drug for peanut allergy, but its sales were hampered by the Covid-19 pandemic.

The post Nestlé Sells Peanut Allergy Drug, Ending the Food Giant’s Foray Into Biotech appeared first on MedCity News.

]]>
44214
3 Reasons Why The Biopharma M&A Market Is Ready For Takeoff https://medcitynews.com/2023/08/biopharma-mergers-acquisitions-ipo/ Mon, 21 Aug 2023 20:52:58 +0000 https://medcitynews.com/?p=645957

Healthcare M&A deals are expected to pick up over the next few months, and one expert is predicting that the biopharma sector in particular will see especially robust activity. M&A lawyer Matt Gardella said there are three sets of market circumstances that will lead to an influx of biopharma deals: a looming patent cliff, shrinking valuations and a weak IPO market.

The post 3 Reasons Why The Biopharma M&A Market Is Ready For Takeoff appeared first on MedCity News.

]]>
43983
Healthcare M&A Activity Reaches 3-Year Low, But It Might Pick Up in the Back Half of ‘23 https://medcitynews.com/2023/08/healthcare-deals-investment/ Wed, 09 Aug 2023 19:48:11 +0000 https://medcitynews.com/?p=644772

M&A activity in the healthcare sector continued to decline in the second quarter of 2023, with the number of deals reaching its lowest point in three years. However, a new report predicted that M&A activity could increase in the second half of this year due to healthcare companies’ continually shrinking valuations and their divestitures of non-core assets.

The post Healthcare M&A Activity Reaches 3-Year Low, But It Might Pick Up in the Back Half of ‘23 appeared first on MedCity News.

]]>
43800
Hospital M&A Activity Caught Up to Pre-Pandemic Levels in Q2 https://medcitynews.com/2023/07/hospital-merger-acquisition-healthcare-kaufman-hall/ Sun, 16 Jul 2023 15:11:55 +0000 https://medcitynews.com/?p=641760

M&A activity among hospitals and health systems increased in Q2 of 2023 — there were 20 deals in Q2 compared to 15 deals in Q1, according to a new report. This surge brought Q2’s M&A activity levels in line with those observed before the pandemic. Q2’s 20 deal marks the highest number of announced transactions for hospitals and health systems since Q1 of 2020.

The post Hospital M&A Activity Caught Up to Pre-Pandemic Levels in Q2 appeared first on MedCity News.

]]>
43392
Thermo Fisher Adds Real-World Evidence to Remit Via $912M CorEvitas Acquisition https://medcitynews.com/2023/07/thermo-fisher-adds-real-world-evidence-to-remit-via-912m-corevitas-acquisition/ Thu, 06 Jul 2023 17:39:23 +0000 https://medcitynews.com/?p=640683

CorEvitas brings Thermo Fisher Scientific registries that gather data about how approved therapies are working in the real world. The acquisition will complement PPD, the contract research organization that Thermo Fisher purchased in 2021.

The post Thermo Fisher Adds Real-World Evidence to Remit Via $912M CorEvitas Acquisition appeared first on MedCity News.

]]>
43242
Why UnitedHealth Group Is Going All in on Amedisys https://medcitynews.com/2023/07/unitedhealth-optum-acquisition-home-care/ Sun, 02 Jul 2023 13:32:07 +0000 https://medcitynews.com/?p=639993

UnitedHealth Group’s Optum is acquiring Amedisys through an all-cash transaction for $101 per share, the companies announced Monday. The move represents a continuing shift to home-based care, several experts said.

The post Why UnitedHealth Group Is Going All in on Amedisys appeared first on MedCity News.

]]>
43137
PwC: Healthcare Deals Remained Strong in 2023 Despite Headwinds https://medcitynews.com/2023/06/healthcare-deals-mergers-acquisitions-headwinds/ Thu, 22 Jun 2023 22:30:26 +0000 https://medcitynews.com/?p=639174

In the 12 months leading up to May 15, health services deal volumes decreased just 4% from the year prior, a new report from PwC found. There was a 15% decrease in deal values.

The post PwC: Healthcare Deals Remained Strong in 2023 Despite Headwinds appeared first on MedCity News.

]]>
43026
Eli Lilly Bets $2.4B on Dice Therapeutics’ Oral Drugs for Psoriasis and More https://medcitynews.com/2023/06/eli-lilly-acquisition-psoriasis-immunology-drugs/ Tue, 20 Jun 2023 17:38:51 +0000 https://medcitynews.com/?p=638712

Eli Lilly’s acquisition of Dice Therapeutics comes eight months after the biotech reported positive data from a Phase 1 study in psoriasis. Dice develops oral small molecule drugs intended to offer alternatives to biologic drugs that are injected or infused.

The post Eli Lilly Bets $2.4B on Dice Therapeutics’ Oral Drugs for Psoriasis and More appeared first on MedCity News.

]]>
42963
How California’s New Legislation Could Affect Healthcare M&A Activity https://medcitynews.com/2023/06/california-mergers-acquistions-healthcare/ Tue, 13 Jun 2023 20:23:27 +0000 https://medcitynews.com/?p=638034

Healthcare dealmakers must prepare for a new law and a recently-introduced bill in the California Senate, both of which aim to increase oversight in the healthcare M&A space. This is a legislative trend other states are beginning to participate in too — such as New York, Massachusetts and Connecticut.

The post How California’s New Legislation Could Affect Healthcare M&A Activity appeared first on MedCity News.

]]>
42861
Novartis Lines Up $3.2B Deal for Kidney Disease Drugs, But FTC Questions Loom https://medcitynews.com/2023/06/novartis-rare-kidney-disease-drugs-merger-acquisition-ftc/ Tue, 13 Jun 2023 17:02:28 +0000 https://medcitynews.com/?p=637980

Novartis is acquiring Chinook Therapeutics in a $3.2 billion deal that brings two late-stage drug candidates for a rare kidney disorder. The Novartis drug pipeline already has a molecule in late-stage development for the same kidney disease, which could raise questions from antitrust regulators.

The post Novartis Lines Up $3.2B Deal for Kidney Disease Drugs, But FTC Questions Loom appeared first on MedCity News.

]]>
42855
FTC Files Suit to Block Amgen’s $28B Buyout of Horizon Therapeutics https://medcitynews.com/2023/05/ftc-lawsuit-amgen-horizon-therapeutics-antitrust-monopoly/ Tue, 16 May 2023 21:26:48 +0000 https://medcitynews.com/?p=634831

The Federal Trade Commission is suing to stop Amgen’s acquisition of Horizon Therapeutics. But rather than claiming product overlap, the agency contends Amgen will use its influence to keep at bay competition for Horizon’s products.

The post FTC Files Suit to Block Amgen’s $28B Buyout of Horizon Therapeutics appeared first on MedCity News.

]]>
42408
Kaiser Permanente to Acquire Geisinger, Along with 5-6 More Health Systems in the Near Future https://medcitynews.com/2023/04/kaiser-permanente-acquire-geisinger-hospital-merger/ Wed, 26 Apr 2023 21:56:23 +0000 https://medcitynews.com/?p=632598

Kaiser Permanente announced that it expects to acquire Pennsylvania-based Geisinger Health. Kaiser’s move is part of a larger plan — Geisinger will be the first health system to join Risant Health, a new company Kaiser launched to operate nonprofit health systems under value-based care models. Kaiser said it expects to invest $5 billion in Risant and fold five or six health systems into the company over the next five years.

The post Kaiser Permanente to Acquire Geisinger, Along with 5-6 More Health Systems in the Near Future appeared first on MedCity News.

]]>
42114
Adaptimmune, TCR2 Therapeutics to Combine in Marriage of Cell Therapy Developers https://medcitynews.com/2023/03/adaptimmune-tcr2-therapeutics-to-combine-in-marriage-of-cell-therapy-developers/ Mon, 06 Mar 2023 22:09:28 +0000 https://medcitynews.com/?p=626430

Adaptimmune and TCR2 Therapeutics have complementary technologies and an aligned strategy of developing cell therapies for solid tumors, but this marriage is preceded by divorce. Before consummating the TCR2 deal, Adaptimmune ended an alliance with a larger pharmaceutical company.

The post Adaptimmune, TCR2 Therapeutics to Combine in Marriage of Cell Therapy Developers appeared first on MedCity News.

]]>
41286
Will it? Won’t It? CVS Health To Finally Acquire Oak Street Health for $10.6B https://medcitynews.com/2023/02/will-it-wont-it-cvs-health-to-finally-acquire-oak-street-health-for-10-6b/ Wed, 08 Feb 2023 21:19:40 +0000 https://medcitynews.com/?p=623419

Rumors of the deal first surfaced in January, with some dismissing the idea. Several experts say the deal makes sense for CVS Health, as it looks to expand into primary and value-based senior care.

The post Will it? Won’t It? CVS Health To Finally Acquire Oak Street Health for $10.6B appeared first on MedCity News.

]]>
40893
Sun Pharma Strikes $576M Deal to Get Hair Loss Drug to Rival Lilly, Pfizer Meds https://medcitynews.com/2023/01/sun-pharma-strikes-576m-deal-to-get-hair-loss-drug-to-rival-lilly-pfizer-meds/ Thu, 19 Jan 2023 18:24:47 +0000 https://medcitynews.com/?p=621031

Sun Pharmaceuticals is acquiring Concert Pharmaceuticals, a biotech whose lead program has positive data from two late-stage clinical trials in alopecia areata. The deal gives Sun Pharma a drug candidate that could match up against hair loss drugs from two big pharmaceutical companies.

The post Sun Pharma Strikes $576M Deal to Get Hair Loss Drug to Rival Lilly, Pfizer Meds appeared first on MedCity News.

]]>
40575
CVS Health Makes Waves During JPM: Experts Weigh In https://medcitynews.com/2023/01/cvs-health-makes-waves-during-jpm-experts-weigh-in/ Wed, 11 Jan 2023 20:32:44 +0000 https://medcitynews.com/?p=620161

CVS Health announced investments this week in Carbon Health, Monogram Health and Array Behavioral Care. There have also been rumors that the company is exploring a $10 billion deal with primary care company Oak Street Health.

The post CVS Health Makes Waves During JPM: Experts Weigh In appeared first on MedCity News.

]]>
40455
LeanTaaS Acquires Hospital IQ to Create $1B Healthcare Automation Company https://medcitynews.com/2023/01/leantaas-acquires-hospital-iq-to-create-1b-hospital-automation-company/ Tue, 10 Jan 2023 21:33:53 +0000 https://medcitynews.com/?p=620023

LeanTaaS acquired healthcare automation company Hospital IQ. The two companies made the deal because their products complement each other — Hospital IQ provides staff optimization solutions, while LeanTaaS makes software to optimize capacity for operating rooms, infusion centers and inpatient beds.

The post LeanTaaS Acquires Hospital IQ to Create $1B Healthcare Automation Company appeared first on MedCity News.

]]>
40434
All About Access: The Key Trends In Retailers’ Acquisitions in 2022 https://medcitynews.com/2022/12/all-about-access-the-key-trends-in-retailers-acquisitions-in-2022/ Mon, 19 Dec 2022 21:12:02 +0000 https://medcitynews.com/?p=617989

Whether it was Amazon’s buy of One Medical or CVS Health’s acquisition of Signify Health, retailers made waves in healthcare this year. Across all of the deals, it’s clear that expanding access to medical services is the key goal, experts said. And this is only the beginning.

The post All About Access: The Key Trends In Retailers’ Acquisitions in 2022 appeared first on MedCity News.

]]>
84934
Does the Rumored Amwell/Talkspace Deal Make Sense? Experts Weigh In https://medcitynews.com/2022/11/do-the-amwell-talkspace-acquisition-rumors-make-sense-experts-weigh-in/ Wed, 30 Nov 2022 22:24:34 +0000 https://medcitynews.com/?p=615469

Some industry experts seem skeptical of the rumored deal between Amwell and Talkspace, while others disagree. The rumored purchasing price is $200 million at about $1.50 per share.

The post Does the Rumored Amwell/Talkspace Deal Make Sense? Experts Weigh In appeared first on MedCity News.

]]>
84836